Parvalbumin (PA), one of the Ca2"-binding neuronal marker proteins, has been revealed to exist in the myelinated axons of the posterior root of the spinal cord and the peripheral nerve of rats. To investigate the role of PA for the genesis of diabetic neuropathy, the levels of PA in the sciatic nerve of normal and streptozotocin-induced diabetic rats were measured by radioimmunoassay (RIA) for PA. The immunohistochemical distribution of PA in the sciatic nerve from both groups was also studied. The RIA for PA revealed that the levels of PA in the sciatic nerve of diabetic rats were significantly decreased when compared with those of normal rats. However, the contents of S-100 protein, another type of Ca2+-binding glial marker protein, did not show any significant difference in the sciatic nerve from both groups. Immunohistochemically, the amount of PA containing myelinated axons of the diabetic nerve was markedly decreased when compared with nondiabetic subjects. These results suggest that the decreased level of PA in the peripheral nerve might contribute to the genesis of diabetic neuropathy.
Introduction
Ca2" is involved in many biological functions and requires the presence of specific intracellular Ca2+-binding proteins to exert its regulatory roles (1, 2) . In the diabetic nervous system, it is known that some disturbance ofCa2+-dependent functions such as axonal transport or cell excitability exists (3) (4) (5) . Thus, Ca2' has been considered an important factor in clarifying the pathogenesis of diabetic neuropathy. However, the molecular basis of such a disturbance remains unclear.
Two different Ca2'-binding proteins exist in the nervous tissues, namely parvalbumin (PA)' and S-100 protein (S-100).
PA was found in type IIB skeletal muscle fibers (6) . The relaxing speed of these muscle fibers increased linearly with the concentrations of this protein. Thus PA is regarded as a relaxing factor ofthe skeletal muscle (7) . In describing the central nervous system, Celio and Heizmann suggested that PA was a marker of a distinct subpopulation of neurons such as Purkinje neurons of the cerebellum and nonpyramidal neurons of the cerebrum (8) .
S-100 is a nervous tissue-specific protein that is mainly located in astrocytes ofthe central nervous tissues and in Schwann Address correspondence to Dr. Endo.
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1. Abbreviations used in this paper: PA, parvalbumin; S-100, S-100 protein; Sciatic N., sciatic nerve; STZ, streptozotocin. cells in the peripheral nerve (9, 10) . Although the exact biological function of S-i 00 remains unknown, it may play a role in microtubule assembly (11) and contribute to the maturation of glial elements (12) .
We previously reported rapid purification procedures for PA and S-100 (13, 14) and developed sensitive assay systems for these proteins using specific antiserum against rat skeletal muscle PA and bovine brain S-100 (15, 16) .
In the present study, we measured the levels of PA and S-100 in the peripheral nerves of normal and diabetic rats to clarify the role ofCa2"-binding proteins for the genesis ofdiabetic neuropathy. We also used immunohistochemical methods to analyze the distributions of PA containing axon in the peripheral nerves.
Methods
Animals. Diabetes mellitus was induced in 250-300-g male Wistar rats with a peritoneal injection of 50 mg/kg streptozotocin (STZ) dissolved in 0.1 M citrate buffer. Control rats were sham injected with the buffer alone. Rats were fed standard chow and allowed free access to water. The blood glucose concentration (nonfasting) was measured in the blood obtained by cardiac puncture.
Preparation ofrat skeletal muscle PA and bovine brain S-bOb and the production of their antiserum. Rat skeletal muscle PA and bovine brain S-lOOb were purified by the methods previously described (13, 14) . Antisera to rat skeletal muscle PA and bovine brain S-lOOb were raised S-1 0 0 (ng) , , t~~~~R in rabbits. The specificity of the antisera to PA and S-100 has been published elsewhere (15) (16) (17) (18) . Radioimmunoassay (RIA) for PA and S-100. The RIA for PA was performed as described previously (15) . The RIA for S-100 was carried out essentially by the same procedures as those for PA. In brief, bovine brain S-I00b was iodinated with Bolton-Hunter reagent, which produced '251-labeled S-100b with a specific radioactivity of 504 Ci/mmol. RIA of S-100b was carried out in 0. material was removed by centrifugation at 3,000 rpm for 10 min, and the supernatant solution was used for the assay. The sensitivity and crossreactivity of the RIA for PA and S-100 is shown in Fig. 1 (Fig. 2 a) , and PA-containing fibers were observed in Rexed lamina II (Fig. 2 b) . In the white matter, PA-positive myelinated axons were observed in anterior funiculus and lateral funiculus (Fig. 2 c) . In posterior funiculus, the axons in the fasciculus cuneatus contained PA, but we could not detect PA immunoreactivity in the fasciculus gracilis (Fig.  2 b) . Note that PA-positive myelinated axons exist in the posterior root (Fig. 2 b) , but no immunoreactivity was seen in the anterior root (Fig. 2 c) . This suggests that PA-containing fiber might be correlated with sensory nerve.
The contents of PA in the peripheral nerve of normal and STZ-induced diabetic rats. Blood glucose concentrations (nonfasting) of the rats from the different protocols are shown in Table I ( Table I ). On the other hand, no significant difference was observed in the contents of S-100 in the Sciatic N., when diabetic and normal subjects were compared (Table I) .
Immunohistochemical .%W,% diabetic Sciatic N. Fig. 3 a shows the PA immunoreactivity in the Sciatic N. of normal rats. Some but not all myelinated axons were heavily stained with antiserum to parvalbumin. The rare appearance of PA positive fibers in the Sciatic N. ofdiabetic rats (Fig. 3 b) supports the results of RIA for PA shown in Table I . Fig. 3 c shows the S-100 immunoreactivity in the Sciatic N. of normal rats. S-100 is located in the cytoplasm of Schwann cells, but no significant difference was observed in its distribution and staining intensity when diabetic and nondiabetic subjects were compared (Fig. 3, c and d) .
Discussion
It has been reported that between 10 and 25% ofdiabetic patients have symptomatic neuropathy, which includes sensory impairment of peripheral nerves (20) . Because Ca2+ is an important factor regulating cellular excitability and axonal transport in neurons (3) (4) (5) , it is reasonable to postulate that an alteration of the levels of intracellular Ca2' or Ca2`-binding proteins perturb the normal functions of the neurons.
Therefore, we investigated here the distribution ofPA, Ca2+-binding neuronal marker protein, in the spinal cord and the peripheral nerve of normal rats. We found that PA exists only in the posterior root, suggesting that it contains fiber correlated with sensory nerve. In addition, we revealed by RIA that in diabetic peripheral nerves, the contents of PA significantly decreased as a function of time, while S-100 did not show any significant change. We confirmed immunohistochemically that the number of PA containing myelinated fibers was lower in diabetic nerves. Accordingly, the results suggest that the alteration of levels of PA in the peripheral nerves might contribute to the pathogenesis of diabetic neuropathy.
Although the role ofPA in the neurons remains unclear, the information presented here provides a clue to clarifying the pathogenesis of diabetic neuropathy.
